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Abstract
Background:  External  catheters  (ECs)  are  commonly  used  in  children  who  are  receiv-
ing  treatment  for  acute  leukemia.
Aims:  To  study  the  spectrum  of  microorganisms  and  to  compare  the  rates  of  infec-
tion.
Methods:  A  total  of  42  ECs  were  inserted,  including  28  Port-A-Caths,  11  CVC  lines
and  3  Hickman  lines.  Single  ECs  were  required  for  19  patients  (45.2%),  whereas  2,  3
and  4  ECs  were  required  in  8,  1  and  1  patients,  respectively.
Results:  Overall,  37  culture-documented  infections  were  present  in  18  (62%)  patients
who  had  ECs.  Gram-positive  microorganisms  were  identiﬁed  in  20  cases,  Gram-
negative  microorganisms  in  14  cases  and  fungal  infections  in  3  cases.  Of  the  42
devices  implanted,  10  out  of  28  Port-A-Caths  (35.7%),  2 out  of  3  Hickman  catheters
(66.7%)  and  9  out  of  11  central  venous  catheters  (81.8%)  required  removal  due  to
infection.  The  average  length  of  working  life  for  the  ports  was  330.6  days  (range:
40—1043  days).  The  median  rate  of  complications  due  to  infection  was  2.84  infec-
tions  per  1000  catheter  days  (interquartile  range:  −1.55  to  5.8),  and  the  number  of
infections  was  correlated  with  the  number  of  ports  (Pearson’s  r =  0.51;  p  <  0.05).
©  2013  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.∗ Corresponding author at: Sultan Qaboos University Hospital,
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anagement  of  acute  leukemia,  although  the
eed, optimal  timing  of  insertion  and  type  of  ECs
sed are  variable  [1—4]. Individual  circumstances
 Sciences. Published by Elsevier Ltd. All rights reserved.
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(pectrum  of  external  catheter-related  infections  in
ay  vary,  but  early  placement  is  often  desirable,
s these  patients  become  neutropenic  soon  after
herapy  is  begun.
Several types  of  ECs  can  be  differentiated  either
y the  type  of  vessel  they  occupy  (i.e.  peripheral
enous, central  venous  (CVC),  or  arterial),  their
ite of  insertion  (i.e.  subclavian,  femoral,  internal
ugular,  peripheral,  and  peripherally  inserted  cen-
ral catheter)  or  their  pathway  from  skin  to  vessel
i.e. tunneled  (Hickman)  versus  non-tunneled  (Port-
-Cath)).  The  use  of  ECs  and  their  relationship  to
lood stream  infection  rates  are  inﬂuenced  by  sev-
ral factors,  some  of  which  are  patient-related,
uch as  severity  of  illness  and  type  of  illness,
r catheter-related,  including  the  condition  under
hich the  catheter  was  placed  and  the  catheter
ype. Other  factors  could  be  institutional,  such  as
ed size,  local  hygiene  and  cleanliness,  and  medical
ersonnel  care,  among  other  considerations  [5].
This study  was  undertaken  to  compare  the  rates
f infection  with  ECs  (Port-A-Cath,  central  venous
atheters,  Hickman  lines)  in  children  with  culture-
roven  infections  receiving  treatment  for  acute
eukemia and  to  study  the  spectrum  of  microor-
anisms cultured  in  these  patients.  Although  these
evices are  extremely  necessary,  they  pose  a seri-
us risk  of  increased  morbidity  and  mortality  [6].
he increased  risk  is  due  to  higher  incidences  of
nfection,  thrombosis,  mechanical  occlusions  and
ther complications  [6—8].
aterials and methods
fter  obtaining  ethical  review  approval,  a  ret-
ospective  study  of  the  medical  records  was
onducted. The  hospital  medical  record  database
as searched  for  all  admissions  with  ICD-10  codes
elated  to  acute  leukemia.  All  such  records  were
ndividually reviewed  to  identify  patients  with
VCs, Hickman  lines  and  Port-A-Cath  insertions.  All
nserted Port-A-Cath  devices  were  the  lightweight
nd durable  titanium/polyurethane  portal  reservoir
ype that  were  kink-resistant,  biocompatible,  MRI-
ompatible,  latex-free,  PVC-free  and  radiopaque
Celsite®,  Aesculap,  Inc.,  Center  Valley,  PA,  USA).
nfections  were  deﬁned  using  the  Centers  for  Dis-
ase Control  (CDC)  criteria  for  catheter-related
lood stream  infections  [9].
This retrospective  study  covered  a  two-year
eriod (2009—2010).  Incidentally,  there  were  50
atients  with  acute  leukemia  that  were  enrolled
onsecutively during  the  study  period.  The  median
ge (±SD)  was  5  ±  3.3  years.  There  were  43  patients
ith  acute  lymphoblastic  leukemia  (ALL),  whereas
 cases  had  acute  myelogenous  leukemia  (AML).
t
i
1
rldren  with  acute  leukemia  39
ll  ALL  patients  were  treated  using  a  standard
rotocol [MRC-UKALL  2003],  whereas  AML  patients
eceived  AML-15  chemotherapy  according  to  the
urrent departmental  treatment  policy  for  acute
eukemia  at  our  institution.  Data  were  collected
rom patient-speciﬁc  leukemia  protocol  ﬂow  sheets
egarding  demographics  and  blood  counts  (white
lood  cells  (WBCs),  absolute  neutrophil  count
ANC), hemoglobin  and  platelets)  at  the  time  of
iagnosis.  Additionally,  EC  type  and  the  date  of  EC
lacement  were  noted.  All  devices  were  inserted
n the  operating  room  using  a full  aseptic  tech-
ique under  ﬂuoroscopic  guidance.  A  chest  X-ray
as taken  to  conﬁrm  the  correct  position  of  the
ip of  the  catheter.  Nurses  trained  in  the  care  of
Cs performed  dressing  changes,  which  involved
kin preparation  at  the  insertion  site  with  an  iodine
olution and  a sterile  dressing.  Patients  suspected
f having  an  EC-related  infection  had  blood  cul-
ures taken  from  both  the  device  and  a  peripheral
ein. Patients  were  considered  to  have  an  EC-
elated infection  if  they  had  a fever  of  38 ◦C  or
ore without  any  obvious  cause  or  had  fever  and
igors associated  with  ﬂushing  of  the  ECs.  Line  ﬂush-
ng with  a  dilute  heparin  solution  was  undertaken
henever CVC  and  Hickman  lines  were  accessed.
tatistical analysis
ormally  distributed  continuous  variables  were
xpressed  as  means  ±  standard  deviations.  How-
ver, continuous  variables  that  were  not  normally
istributed were  expressed  as  medians  with
nterquartile ranges.  Categorical  variables  were
xpressed  as  percentages.  Port  complications  were
orrelated using  Pearson’s  correlation  coefﬁcient.
ifferences were  considered  to  be  signiﬁcant  when
 <  0.05,  and  all  analyses  were  performed  using  SPSS
ersion 15.0  for  Windows.
esults
Cs
able  1  summarizes  the  patient  demographic  char-
cteristics.  A  total  of  42  ECs  were  placed  in
9/50 (58%)  patients  with  a total  period  of  12,271
atheter  days.  The  average  length  of  working  life
or the  ports  was  330.6  days  (range:  40—1043  days)
Table  2).  In  28,  11  and  3  patients,  single  or  mul-
iple Port-A-Caths,  CVCs  or  Hickman  lines  were
nserted,  respectively.  Single  ECs  were  required  for
9 patients  (45.2%),  whereas  2,  3  and  4  ECs  were
equired  in  8,  1  and  1  patients,  respectively.
40  
Table  1  Demographic  and  clinical  characteristics  of
patients  with  external  devices  (n  =  29).
Age  (years)
Mean  ±  SD  5.5  ±  4.0
Range  1.0—13
Male  sex,  n  (%) 14  (48)
Female  sex,  n  (%) 15  (52)
Type  of  disease
ALL  Pre-B  ALL,  n  (%)  18  (62)
T-cell  ALL,  n  (%)  2  (7)
Relapsed  ALL,  n  (%)  2  (7)
Infant  ALL,  n  (%)  1  (3)
AML,  n  (%)  6  (21)
Type  of  port
Port-A-Cath  (%)  28  (67)
CVC  (%)  11  (26)
Hickman  (%)  3  (7)
No.  of  ports  (%)  42  (100)
One  port,  n  (%)  19  (45.2)
Two  ports,  n  (%) 8  (38.1)
Three  ports,  n  (%) 1 (7.1)
Four  ports,  n  (%) 1  (9.5)
Duration  of  port,  days  (range) 331  (40—1043)
No.  of  organisms
All  cases,  n  (%) 37  (100)
Gram-positive,  n  (%) 19  (51.4)
Gram-negative,  n  (%) 15  (40.5)
Fungal,  n  (%) 3  (08.1)
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antibiotics,  crystalloids  and  colloids  and  parenteral
nutrition. However,  as  a hospital  policy,  the  third
lumen, if  available,  is  reserved  for  parenteralInfections
Overall,  37  culture-documented  infections  were
found in  18  (62%)  patients  who  had  ECs.  There  were
no organisms  identiﬁed  in  11  (38%)  cases,  whereas
12 (41%)  patients  grew  1  organism,  1  (3.5%)  case
each grew  2 and  3  organisms,  2 (7%)  cases  each  grew
4 organisms  and  2  (7%)  cases  each  grew  6  organisms.
Most  cases  with  CVCs  showed  infection  with  multi-
ple organisms.  Infections  developed  in  2  out  of  3
cases with  Hickman  catheters.
Gram-positive  microorganisms  were  identiﬁed
in 54.1%  of  the  positive  cultures,  Gram-negative
microorganisms  in  37.8%  cultures  and  fungal  infec-
tions in  8.1%  cultures  (Table  3).  The  Gram-positive
organisms isolated  were  coagulase-negative
Staphylococcus  (11),  S.  aureus  (2),  Bacillus  spp.
(2) and  one  each  of  Streptococcus  hemolyticus,
Streptococcus  salivarius, Streptococcus  viridians,
Micrococcus spp.  and  Staphylococcus  epidermidis.
The Gram-negative  organisms  isolated  were  Kleb-
siella pneumoniae  (5),  Escherichia  coli  (4),  and
one each  of  Pseudomonas  aeruginosa, Ps.  putida,
Acinetobacter  baumannii, Haemophilus  inﬂuenzae
and Enterobacter  cloacae. tM.  Zachariah  et  al.
utcomes
isk  stratiﬁcation  in  acute  leukemia  is  important
or selecting  the  appropriate  therapy  and  predict-
ng outcomes.  Patients  are  generally  classiﬁed  as
ow (standard)  risk,  intermediate  and  high  risk
ased on  demographics,  laboratory  markers  of
umor burden  and  cytogenetic  features.  Low-risk
standard)  cases  have  favorable  demographics  and
aboratory  features  with  no  cytogenetic  abnormal-
ties. Intermediate-risk  patients  have  unfavorable
emographics and  laboratory  features  but  have  no
bnormal cytogenetic  features.  High-risk  patients
ave unfavorable  demographics  and  laboratory  fea-
ures, present  cytogenetic  abnormalities  and  have
oor responses  to  initial  therapy.
Of the  42  devices  implanted,  10  out  of  28  (35.7%)
ort-A-Caths, 2  out  of  3  (66.7%)  Hickman  catheters,
nd 9  out  of  11  (81.8%)  CVCs  required  removal  due
o infection.  Twenty-four  children  were  stratiﬁed
s standard  risk.  In  this  group,  6  patients  had  ECs
all Port-A-Caths),  but  only  4  became  infected;  only
 EC  had  to  be  removed.  Twenty-six  children  were
tratiﬁed  as  intermediate-  and  high-risk  patients,
ith a  total  of  36  EC  insertions.  In  this  group,
2 Port-A-Caths  were  inserted,  14  of  which  devel-
ped  infections,  with  10  ports  needing  removal
ue to  infection.  Because  of  infection,  9  out  of
1 CVC  lines  and  2  out  of  the  3  Hickman  lines
ad to  be  removed.  Thus,  patients  with  high-  and
ntermediate-risk  disease  had  more  EC  insertions
nd more  infections  than  patients  with  standard-
isk disease.
iscussion
Cs  such  as  Port-A-Caths,  CVCs  and  Hickman
ines are  extremely  useful  devices  for  patients
ho require  continuous,  uninterrupted  long-term
enous access  during  chemotherapy  schedules  for
he management  of  acute  leukemia.  However,
hese devices  are  often  associated  with  com-
lications that  include  occlusion,  infection  and
hrombosis  [1,2,10,11].
In our  hospital,  the  Hickman  catheters  used  are
ual-lumen  and  are  not  coated  with  antimicrobials,
ntiseptics or  nanoparticles.  The  central  venous
atheters  are  either  double-  or  triple-lumen  and
re not  coated  with  any  antibiotics.  We  restrict  the
se of  one  lumen  for  blood  and  blood  products,
hereas the  other  lumen  is used  for  administeringherapy in  patients  who  require  it.  The  interval
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Table  2  Correlation  of  port  infections  with  port  survival  times  in  29  patients.
Type  of  port  No.  of
ports
No. of
organisms
No.  of
days  of
port  1
No.  of
days  of
port  2
No.  of
days  of
port  3
No.  of
days  of
port  4
Total  no.
of  days
with  port
No.  of
infections/1000
port  days
PC  1  0  365  365
PC  1  0  730  730
PC/CVC  2  0  256  65  321
PC  1  1  1043  1043  0.96
PC  1  0  1122  1122
PC  1  0  1078  1078
H  1  0  130  130
PC  1  1  178  178
PC/CVC  2  2  100  96  196  10.2
PC/H  2  1  108  54  162  6.17
PC/H  2  6  107  40  147  40.8
PC  1  0  789  789
PC  1  0  809  809
PC  1  1  723  723  1.38
PCX2/CVC  3  3  66  100  91  257  11.67
PCX2  2  1  384  200  584  1.71
PC  1  0  81  61  142
PC  1  0  586  586
PC/CVC  2  6  26  21  47  127.65
CVC  1  1  299  299  3.34
PC  1  1  437  437  2.28
CVC  1  0  248  248
PC  1  1  711  711  1.4
PC  1  1  332  332
PC  1  1  352  352  2.84
CVC’sX2/PCX2 4  4  29  3  45  22  99  40.4
PC  1  1  177  177  5.64
CVCX2  2  4  18  22  40  100
PC/CVC  2  1  107  60  167  5.98
Total 42  37  11,391  722  136  22  12,271
Average  no.  of  days/port  =  330.61  (range  40—1043)
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etween  port  needle  puncture  was  usually  between
 and  7 days,  and  needles  were  always  removed  at
ischarge or  when  the  use  of  parenteral  therapy
as no  longer  needed.  If  the  catheter  was  removed
ue to  infection,  a  new  catheter  was  inserted.  How-
ver, if  there  was  no  further  need  of  parenteral
herapy, we  chose  not  to  reinsert  another  catheter.
ur data  certainly  indicate  that  the  presence  of
urrent infection  was  a  high  risk  for  re-infection.
owever, we  needed  to  reinsert  a  port/catheter
ecause of  poor  venous  access  when  the  patients
ere on  intense  chemotherapy  and/or  supportive
herapy. We  do  not  administer  prophylactic  antibi-
tics to  these  patients.  Antibiotics  are  only  started
fter suspicion  or  if  evidence  of  culture-proven
nfection  is  available.  Despite  being  on  antibiotics,
e observed  that  approximately  one-third  of  the
atients  in  our  study  cohort  developed  infection
ith a  different  organism  (Table  2).
p
c
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The  most  important  cause  for  the  removal  of  ECs
n this  cohort  of  patients  was  infection,  similar  to
ata presented  in  other  studies  [1,2,10,11]. Over-
ll, infections  in  ECs  were  observed  at  a  rate  of
.84 infections  per  1000  catheter  days  (interquar-
ile range:  1.55—5.8),  and  the  number  of  infections
as correlated  with  the  number  of  ports  (Pearson’s
 =  0.51;  p  < 0.05).  A  literature  review  shows  that
nfections  in  ECs  vary  from  1.8  to  3.4  infections
er 1000  catheter  days  [4,11]. Combined  data  from
 studies  involving  320  pediatric  oncology  patients
evealed  an  infection  rate  for  ECs  of  2.2  infections
er 1000  catheter  days  [12].
Most of the  CVC  and  Hickman  lines  and  35%
f Port-A-Cath  devices  had  to  be  removed  due  to
nter-current  infections  that  were  documented  by
ositive cultures.  This  outcome  likely  reﬂects  the
ombination  of  nursing  care  and  patient  hygiene
nd needs  to  be  improved  by  strict  implementation
42  M.  Zachariah  et  al.
Table  3  Numbers  and  types  of  organisms  isolated  during  episodes  of  infection.
Isolated  microorganisms  No.  Port-A-Cath  Hickman  CVC  line
Gram-positive  (n  =  20,  54.1%)
Staphylococcus  aureus  (MRSA)  2  2
Staphylococcus  epidermidis  1  1
Coagulase-negative  Staphylococcus  11  8  1  2
Staphylococcus  hemolyticus  1  1
Streptococcus  salivarius 1 1
Streptococcus  viridans 1 1
Micrococcus  species 1 1
Bacillus  spp.  2  2
Gram-negative  (n  =  14,  37.8%)
Klebsiella  pneumoniae  5  1  4
Escherichia  coli  4  1  3
Pseudomonas  aeruginosa 1 1
Pseudomonas  putida 1 1
Acinetobacter  baumannii 1 1
Enterobacter  cloacae 1 1
Haemophilus  inﬂuenzae 1 1
Fungi  (n  =  3,  8.1%)
Candida  krusei  (Issatchenkia  orientalis)  1  1
Candida  tropicalis  1  1
Candida  kefyr  1  1
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of  the  recommended  guidelines  [5].  The  number  of
infections  per  1000  port  days  was  lowest  in  patients
with Port-A-Caths,  ranging  between  0.96  and  5.64;
Hickman lines  had  an  intermediate  infection  inci-
dence that  ranged  from  6.17  to  40.8  per  1000  port
days. However,  infection  incidence  was  signiﬁcantly
high in  CVCs,  and  ranging  from  53.3  to  127.65  per
1000 (Table  2).
The  total  number  of  port  days  in  patients  (n  =  11)
who did  not  grow  microorganisms  in  culture  was
higher (6194)  than  in  patients  (n  =  18)  with  positive
cultures  (5197),  but  this  difference  was  not  statisti-
cally signiﬁcant.  Moreover,  only  12  ports  were  used
in the  former  group  (ratio  1.09),  in  contrast  to  30
ports in  the  latter  group  (ratio,  1.67).  It  is  appar-
ent that  these  numbers  indicate  the  presence  and
effects  of  infection.  However,  because  of  the  small
sample  size,  the  differences  are  not  statistically
signiﬁcant.
In the  5  patients  who  were  managed  with  a
single  port  for  more  than  2 years,  only  1  patient
grew a  single  organism  (blood  culture),  which
reﬂects the  excellent  port  care  employed  by  the
team looking  after  these  patients.  Current  guide-
lines/recommendations  for  management  of  devices
indicate  that  devices  survive  longer  if  they  are
handled by  experienced  staff  from  the  same  cen-
ter using  standardized  protocols  of  care  at  all  times
[6].
c
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F18  3  16
Staphylococcal  infection  seems  to  be  the  most
ommon type  reported  in  the  literature  regarding
C infections,  with  a prevalence  of  almost  90%
4,11,12]. Staphylococcus  was  also  the  most  preva-
ent microorganism  isolated  in  our  study,  but
verall,  Gram-positive  organisms  only  accounted
or 54.1%  of  infections;  a signiﬁcant  proportion  of
ram-negative  infections  was  also  identiﬁed  in  this
tudy (37.8%).
Two patients  developed  polymicrobial  infections
ith 6 organisms  each  (Table  2).  Both  of  these
atients were  high-risk  ALL  cases  that  responded
oorly to  chemotherapy;  1  patient  required  bone
arrow transplantation.  One  patient  who  needed
wo lines  (a  Hickman  line  (107  days)  and  a  Port-
-Cath  (40  days))  developed  mostly  Gram-positive
nfections with  Coagulase-negative  Staphylococ-
us (2),  S.  salivarius, S.  aureus  and  Micrococcus
pecies. Another  patient  who  also  required  two
ines (a  CVC  (26  days)  and  a  Port-A-Cath  (21  days))
eveloped  infections  mainly  with  Gram-negative
rganisms,  namely  K.  pneumoniae, A.  bauman-
ii and  Ps.  putida,  along  with  Candida  krusei
Issatchenkia orientalis). The  microbial  patterns
ere quite  distinct  in  these  two  cases,  with  polymi-
robial  infections  with  Port-A-Cath  and  Hickman
ines  favoring  Gram-positive  infections,  and  CVCs
avoring  Gram-negative  and  fungal  infections.
urthermore, the  CVC  needed  to  be  removed  from
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he  latter  patient  within  a  short  period  of time  (26
ays).
Overall,  multiple  organisms  were  identiﬁed  in
pproximately  one-third  of  infections  (37.5%),  with
ost instances  in  CVCs  and  Hickman  lines.  This  ﬁnd-
ng is  likely  a  reﬂection  of  the  poor  nursing  care  and
atient hygiene,  which  are  essential  for  preventing
nd reducing  such  infections.  Importantly,  most  of
hese ECs  had  to  be  removed.  In  contrast,  Port-
-Caths  with  fewer  infections  have  the  advantage
f decreased  care  requirements  for  patients’  fami-
ies, cause  less  self-consciousness,  allow  for  ease  of
athing and  are  not  prone  to  accidental  removal.
onclusions
he  study  shows  that  although  ECs  in  patients  with
cute leukemia  help  in  facilitating  the  delivery
f chemotherapy  and  parenteral  support,  espe-
ially  during  the  neutropenic  phase,  the  catheters
ncrease  the  risk  of  developing  infections.  Gram-
ositive  organisms,  especially  Staphylococcus,  are
he most  predominant  organisms  involved,  but
ram-negative  organisms  were  also  identiﬁed  in
igniﬁcant  numbers  in  this  study.  CVCs  and  Hick-
an lines  showed  higher  infections  requiring
atheter removal,  reﬂecting  a  lack  of  adherence
o recommended  guidelines  and  demonstrating  the
mportance  of  nursing  care.  Port-A-Caths  were
uch less  likely  to  be  infected.  Overall,  the
ractice of  good  nursing  care  and  recommended
nfection  prevention  guidelines  should  be  imple-
ented and  will  go  a  long  way  in  reducing  these
omplications.
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